Make Informed Investment Decisions with Affordable Access to Experts

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Examining new compounds in development in the NASH and PBC landscape

Ticker(s): GILD, ICPT, AGN

Who's the expert?

Name: Dr Don Rockey - MD

Institution: MUSC

  • Professor and Chairman of our Department of Medicine at MUSC.
  • Clinical research interests revolve around establishing management strategies for patients with common gastrointestinal problems, especially GI bleeding, and the overall direction of these studies has been to help establish national patient management guidelines.
  • Has authored more than 200 scientific papers dealing with GI-related topics and has presented many invited lectures at gastroenterology and hepatology symposia around the United States and throughout the world. 

Interview Goal
This conversation will discuss the current compounds in development and competitive landscape for NASH and PBC patients.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.